www.fdanews.com/articles/138606-taiho-announces-results-of-tas-102-phase-ii-trial-for-metastatic-colorectal-cancer

Taiho Announces Results of TAS-102 Phase II Trial for Metastatic Colorectal Cancer

July 22, 2011

Taiho Pharmaceutical announced the results of a randomized, Phase II clinical trial for the novel oral nucleoside antitumor agent TAS-102 under development by the company for metastatic colorectal cancer.
News-Medical